These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7197975)

  • 1. Pharmacokinetics of amezinium in man.
    Traut M; Brode E
    Arzneimittelforschung; 1981; 31(9a):1605-15. PubMed ID: 7197975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amezinium in rat and dog.
    Traut M; Brode E; Neumann B; Kummer H
    Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of ameziniummetilsulfate in man. Single and repetitive oral administration of a therapeutically effective dose.
    Brode E; Hollmann M; Vollgraf C
    Arzneimittelforschung; 1983; 33(10):1491-7. PubMed ID: 6686052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of amezinium in man.
    Wilsmann K; Neugebauer G; Kessel R; Lang E
    Arzneimittelforschung; 1981; 31(9a):1638-46. PubMed ID: 7197978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of amezinium in humans and animals.
    Traut M; Kummer H; Brode E
    Arzneimittelforschung; 1981; 31(9a):1616-22. PubMed ID: 7197976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of amezinium in humans during passive upright tilt in comparison with norfenefrine and dihydroergotamine.
    Wilsmann K; Neugebauer G; Kessel R; Lang E
    Arzneimittelforschung; 1981; 31(9a):1647-52. PubMed ID: 7197979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action.
    Traut M; Brode E; Hoffmann HD
    Arzneimittelforschung; 1981; 31(9a):1566-74. PubMed ID: 7197971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of 3H-bamethan in humans].
    Hengstmann JH; Steinkamp B
    Arzneimittelforschung; 1981; 31(5):843-8. PubMed ID: 6115653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of exogenous chondroitin sulfate in man.
    Conte A; de Bernardi M; Palmieri L; Lualdi P; Mautone G; Ronca G
    Arzneimittelforschung; 1991 Jul; 41(7):768-72. PubMed ID: 1772467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of amezinium in body fluids.
    Traut M; Morgenthaler H; Brode E
    Arzneimittelforschung; 1981; 31(9a):1589-93. PubMed ID: 7030355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative review of the pharmacokinetics of boric acid in rodents and humans.
    Murray FJ
    Biol Trace Elem Res; 1998; 66(1-3):331-41. PubMed ID: 10050928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
    Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
    J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.